Three Drug Combinations for Late-Stage Trypanosoma brucei gambiense Sleeping Sickness: A Randomized Clinical Trial in Uganda

Open Access

Peer-reviewed

Research Article

Gerardo Priotto ,

*To whom correspondence should be addressed. E-mail: gpriotto@epicentre.msf.org

Affiliation Epicentre, Paris, France
⨯
Carole Fogg,

Affiliation Epicentre, Paris, France
⨯
Manica Balasegaram,

Affiliation Médecins Sans Frontières, Paris, France
⨯
Olema Erphas,

Affiliation National Sleeping Sickness Control Programme, Arua, Uganda
⨯
Albino Louga,

Affiliation National Sleeping Sickness Control Programme, Arua, Uganda
⨯
Francesco Checchi,

Affiliation Epicentre, Paris, France
⨯
Salah Ghabri,

Affiliation Epicentre, Paris, France
⨯
Patrice Piola

Affiliation Epicentre, Paris, France
⨯

Reader Comments (0)

African trypanosomiasis
Is the Subject Area "African trypanosomiasis" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Trypanosoma
Is the Subject Area "Trypanosoma" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.
White blood cells
Is the Subject Area "White blood cells" applicable to this article?

Thanks for your feedback.
Trypanosomiasis
Is the Subject Area "Trypanosomiasis" applicable to this article?

Thanks for your feedback.
Uganda
Is the Subject Area "Uganda" applicable to this article?

Thanks for your feedback.